Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis — MAbomet  

Breast Carcinoma Metastatic to the Bone Clinical Trial

Official title: Prospective Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis

Status Completed

Clinical Trial Summary

Epidemiological, prospective and multicenter study to evaluate the utility of the BOMET-QoL questionnaire in patients with breast cancer (BC) and bone metastases (BM).

Clinical Trial Description

Population: Patients over 18 with breast cancer and bone metastasis.

Inclusion criteria:

• Patient over 18 years of age.

• Patient diagnosed with breast cancer (BC) and bone metastases (BM).

• Patient who has granted informed consent in writing to participate in the study.

• Patient capable of understanding and completing the questionnaires.

Exclusion criteria:

• Patient with another type of disease that, in the investigator's opinion, could mask the study results.

• Patients with a life expectancy of less than 8 months.

• Patient who is participating in a clinical trial with an unregistered drug at the start of the study. ;

Related Conditions & MeSH terms

• Breast Carcinoma Metastatic to the Bone
• Breast Neoplasms
• Neoplasm Metastasis

• NCT number: NCT03847220
• Study type: Observational [Patient Registry]
• Source: Spanish Breast Cancer Research Group
• Status: Completed
• Start date: October 23, 2007
• Completion date: July 7, 2012